4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-043289
President & CEO sold 100,000 shares at an average $31.29 ($3,128,667)
- President & CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-07-23 | Option exercise | +33,333 | $7.21 | $240,331 | 328,659 | D: show line 1 in the form |
| ROBIN HOWARD W President & CEO | 2019-07-23 | Sale | −33,333 | $32.10 | $1,069,989 | 295,326 | D: show line 2 in the form |
| ROBIN HOWARD W President & CEO | 2019-07-24 | Option exercise | +33,334 | $7.21 | $240,338 | 328,660 | D: show line 3 in the form |
| ROBIN HOWARD W President & CEO | 2019-07-24 | Sale | −33,334 | $32.11 | $1,070,355 | 295,326 | D: show line 4 in the form |
| ROBIN HOWARD W President & CEO | 2019-07-25 | Option exercise | +33,333 | $7.21 | $240,331 | 328,659 | D: show line 5 in the form |
| ROBIN HOWARD W President & CEO | 2019-07-25 | Sale | −33,333 | $29.65 | $988,323 | 295,326 | D: show line 6 in the form |
| Open-market sales · 100,000 sh · avg $31.29 · $3,128,667 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-07-23 | Option exercise · Common Stock | −33,333 | 166,667 | D: show line 7 in the form | ||
| ROBIN HOWARD W President & CEO | 2019-07-24 | Option exercise · Common Stock | −33,334 | 132,333 | D: show line 8 in the form | ||
| ROBIN HOWARD W President & CEO | 2019-07-25 | Option exercise · Common Stock | −33,333 | 100,000 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…